Resetting the Scoreboard: Why CBO Should Abandon Its Flawed Analysis of the Center for Medicare and Medicaid Innovation

One of the impediments to repealing and replacing Obamacare has been a belief by the Congressional Budget Office that substantial federal savings will be achieved by innovative demonstration projects in Medicare, Medicaid, and the Children’s Health Insurance Program called for under the law. The CBO bases this conclusion about these savings not on analyses...

Biosimilar Drugs Offer Promise For Drug Price Savings, But Risks Remain

The issue of prescription drug prices continues to top the list of public concerns about health costs, and Congress and the administration are floating possible policy solutions. Solutions to this complex problem will be most effective if they are targeted and geared toward encouraging rather than undermining competition and innovation in the vibrant 21st...

Private Physician Practice Takes Another Blow From A New 2,400-Page Government Rule

Just before former House Speaker John Boehner handed the gavel to Paul Ryan, he shepherded legislation that eliminated a despised Medicare payment formula under which physicians faced a 21.2% pay reduction. Congress could not allow the pay cut to take place and take the risk that physicians would turn away their Medicare patients. But...

MACRA: The Burden of Proof

MACRA:  The Burden of Proof by Carol Monaco The Centers for Medicare and Medicaid Services has released a 2,398-page final rule implementing what is likely the most complex clinician payment program in Medicare’s history, known as the Quality Payment Program, born out of the Medicare Access & CHIP Reauthorization Act of 2015 or MACRA. As...